FindTrial
Sign In

Study of Pre-identified methylation marker gene as a gastric cancer biomarker

Validation and establishment of pre-identified novel gene(s) as gastric cancer biomarker(s) - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061396
Enrollment
76
Registered
2024-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C169- Malignant neoplasm of stomach, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

North Eastern Hill University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Gastric cancer patients attending the surgical oncology OPD. 2. Patients who are willing to participate. 3. Age = 18.

Exclusion criteria

Exclusion criteria: 1. History of combination of other types of cancer. 2. Non-availability of matched cancer and normal tissue from the same patient. 3. Non-availability of patient data.

Design outcomes

Primary

MeasureTime frame
1. Degree of methylation of the proposed genes. 2. Expressional difference of the proposed genes.Timepoint: 1.1st week of participation:Gene expression analysis. 2.2nd week of participation: Gene methylation analysis.—

Secondary

MeasureTime frame
Association between the specific gene methylation with TNM status, Personal habits.Timepoint: 3rd week of participation.—

Countries

India

Contacts

Public ContactSrimoyee Ghosh

North Eastern Hill University

srimoyee2009@gmail.com09774566179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026